OSTX · OS Therapies Inc
$1.71
+0.05 (+3.01%)
At close · Sep 2
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$76.57M
Shares
46.13M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-21 | — | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-12 | 2026-08-06 | |
| 8-K | 2026-08-06 | 2026-07-31 | |
| 8-K | 2026-07-29 | 2026-07-23 | |
| DEF 14A | 2026-07-24 | 2026-09-09 | |
| 8-K/A | 2026-07-07 | 2026-06-30 | |
| 8-K | 2026-07-02 | 2026-06-30 | |
| 10-Q | 2026-05-18 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| 8-K | 2026-04-02 | 2026-03-31 | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-31 | — | |
| 8-K | 2026-03-06 | 2026-03-04 | |
| 8-K | 2026-02-13 | 2026-02-10 | |
| 8-K | 2026-01-12 | 2026-01-10 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-10-21 | — | |
| 8-K | 2025-10-17 | 2025-10-14 | |
| 8-K | 2025-09-30 | — | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-26 | 2025-08-25 | |
| DEF 14A | 2025-08-25 | 2025-10-14 | |
| 8-K | 2025-08-19 | — | |
| 10-Q | 2025-08-18 | 2025-06-30 | |
| 8-K | 2025-08-15 | — | |
| 8-K | 2025-07-14 | 2025-07-11 | |
| 8-K | 2025-06-27 | 2025-06-26 | |
| 8-K | 2025-06-24 | 2025-06-23 | |
| 8-K | 2025-05-16 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-04-15 | 2025-04-09 | |
| 8-K | 2025-04-09 | — | |
| 8-K | 2025-04-02 | 2025-03-31 | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| DEF 14A | 2025-02-28 | 2025-03-31 | |
| 8-K | 2025-01-29 | 2025-01-28 | |
| 8-K | 2025-01-15 | 2025-01-14 | |
| 8-K | 2025-01-14 | 2025-01-10 | |
| 8-K | 2025-01-03 | 2024-12-31 | |
| 8-K | 2024-12-30 | 2024-12-24 | |
| 8-K | 2024-11-15 | — | |
| 10-Q | 2024-11-15 | 2024-09-30 | |
| 8-K | 2024-11-01 | 2024-10-31 | |
| 8-K | 2024-10-28 | — | |
| 8-K | 2024-08-22 | — | |
| 8-K | 2024-08-15 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 10-Q | 2024-05-20 | 2024-03-31 |
Showing 1–50 of 50 filings
Key facts
CIK
1795091
CUSIP
68764Y207
13F (30d)
27 filings
27 filers
Visit website
Investor relations